Company: LGN
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0002052568-25-000018
Chunk: 156

Company: Legence Corp.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 156
---
 meeting following the grant date, subject generally to continued service.The following table summarizes the RSU activity during the nine months ended September 30, 2025 (in thousands, except per share data):RSUsWeighted-Average Grant Date Fair Value per ShareOutstanding as of December 31, 2024—$— Granted620,39028.00 Vested—— Forfeited—— Outstanding as of September 30, 2025620,390$28.00 As of September 30, 2025, unrecognized stock-based compensation expense related to the RSUs was $17.0 million, which is expected to be recognized over a weighted-average period of 2.9 years. For the three and nine months ended September 30, 2025, the Company recognized $0.1 million and $0.2 million of stock-based compensation expense related to RSUs in Cost of revenue and Selling, general and administrative, respectively, on the Condensed Consolidated Statements of Operations. 

32

Legence Corp.Notes to Condensed Consolidated Financial Statements - (Continued)(Unaudited)

The following table summarizes stock option activity during the nine months ended September 30, 2025:Stock OptionsWeighted-Average Grant Date Fair Value per ShareWeighted-Average Exercise Price per ShareOutstanding as of December 31, 2024—$— $— Granted668,57016.46 28.00 Vested—— — Forfeited—— — Outstanding as of September 30, 2025668,57016.46 28.00 Vested and exercisable as of September 30, 2025—$— $— As of September 30, 2025, unrecognized stock-based compensation expense related to stock options was $10.8 million, which is expected to be recognized over a weighted-average period of 3.0 years. For the three and nine months ended September 30, 2025, the Company recognized $0.2 million of stock-based compensation expense related to stock options in Selling, general and administrative on the Condensed Consolidated Statements of Operations. Weighted-average inputs used in the Black-Scholes option pricing model for options granted under the 2025 Omnibus Incentive Plan were as follows:Stock price$28.00Expected term (in years)6.0Expected volatility60.0%Risk-free interest rate3.7%